華策影視(300133.SZ):決定終止公開發行可轉債事項
格隆匯4月26日丨華策影視(300133.SZ)公佈,之前披露,擬發行可轉換公司債券募集資金總額不超過人民幣18億元。
鑑於目前國家政策及資本市場環境變化,並綜合考慮公司發展規劃、資本運作計劃等諸多因素,經公司與中介機構審慎分析、研究與溝通,決定終止公開發行可轉換公司債券事項。
2020年4月24日,公司召開第四屆董事會第八次會議和第四屆監事會第七次會議,審議並通過了《關於終止公開發行可轉換公司債券的議案》,同意終止此次公開發行可轉換公司債券事項。獨立董事對該議案發表了同意的獨立意見。此次終止事項尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.